HF
TNXP icon

HRT Financial’s Tonix Pharmaceuticals TNXP Stock Holding History

HRT Financial’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-27,189
Closed -$486K – 3520
2025
Q1 		$486K Buy
+27,189
New +$551K ﹤0.01% 1474
2024
Q3 		– Sell
-215
Closed -$15K – 3136
2024
Q2 		$15K Buy
+215
New +$97.6K ﹤0.01% 1969
2022
Q1 		– Hold
0
– -$16K – 3862
2021
Q4 		– Hold
0
– – – 2979
2021
Q2 		– Sell
-1
Closed -$445K – 3532
2021
Q1 		$445K Buy
+1
New +$765K ﹤0.01% 1873

Other funds holding TNXP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
SPS
Susquehanna Portfolio Strategies Bala Cynwyd, Pennsylvania $6.73B AUM 45.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HRT Financial's TNXP Position: Q2 2025 in Review

HRT Financial sold out of Tonix Pharmaceuticals (TNXP) in Q2 2025, closing a stake of 27,189 shares — an estimated $486K sold.

HRT Financial first reported a position in TNXP in Q1 2021 and held it in 3 quarters. The position peaked at $486K in Q1 2025. 47 funds tracked by Wall St. Rank hold TNXP as of Q2 2025.

  • HRT Financial reported no remaining Tonix Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 27,189 Tonix Pharmaceuticals shares in Q2 2025, an estimated $486K.
  • HRT Financial first reported a position in Tonix Pharmaceuticals in Q1 2021 and held it in 3 quarters.
  • HRT Financial's Tonix Pharmaceuticals position peaked at $486K in Q1 2025.
  • 47 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.